Dr. Stacy Blain
Co-founder, Chief Scientific Officer and acting CEO
has over 20 years of experience
in cell cycle biology and
has over 20 years of investment management and start-up
Dr. Dominique Bridon
Chief Development Officer
has over 30 years of C-suite executive and scientific leadership.
Chief Operating Officer
has over 25 years of business development and start-up operating expertise.
Dr. Grace Chen
has over 8 years of experience in immunology and cell signaling research.
Keren Paz, PhD
CSO, Stelexis Therapeutics
Gary Schwartz, MD
Division Chief Hem/Onc, Columbia University Medical Center
Neil Rosen, MD, PhD
Molecular Pharmacology and Chemistry Program, MSKCC
Andrew Koff, PhD
Molecular Biology Program, MSKCC
Geoffrey Shapiro, MD, PhD
Director, Early Drug Development Center
Dana-Farber Medical Center
Daniel Heller, PhD